/Investor DB

Claritas Capital — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Genomindgenomind.comin𝕏Apr 2021

GenMedPro is a genetics-based medication management platform that analyzes 26 genes to identify drug-drug and gene-drug interactions across a patient's entire medication regimen.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesKing of Prussia, US

Dr. Ronald Dozoretz(Founder)Stephen Haller(Executive Officer)Gloria Nuss(Executive Officer)Beth E. Dozoretz(Executive Officer, Director)Thomas Hess(Executive Officer)inMichael Koffler(Executive Officer, Director, Promoter)

Board seatJohn ChadwickTheresa Sexton· per SEC Form D

Work&workandsolutions.cominJul 2021

Work& designs, builds, and manages dedicated lactation and wellness rooms for corporate workplaces.

FemTechFuture of WorkHR TechWellness & FitnessHouston, US

Abigail Marks Donnell(Executive Officer, Director)Abbey Donnell(Founder)inJules Lairson(Co-Founder)in

Co-investorsAggie Angel NetworkAlumni VenturesJosephine CollectiveModerne VenturesTexas HALO FundThe Artemis Fund

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.